New program aims to ease distress for advanced lung cancer patients
NCT ID NCT04900935
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new program called POISE for people with stage IV non-small cell lung cancer who are on targeted therapy. The program includes four visits with a specially trained palliative care clinician to help patients cope with uncertainty and manage their cancer. Researchers want to see if the program is practical and helpful for patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALK POSITIVE NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Training healthcare teams to see the whole person behind the illness
- Can immunotherapy be safely used in early lung cancer? a Real-World study investigates
- Can a drug duo outsmart ALK-Positive lung cancer?
- A 6-week coaching program may lift the weight on family caregivers — a study asks if it works.
- Can a single online class help cancer survivors sleep better?
- Can a simple text message transform cancer care?